| Q: |
When is your annual meeting? |
|
A: |
The annual meeting of shareholders will be held on June 7, 2007 from 1:00-2:30 pm at:
Crystal Springs Ballroom
San Mateo Marriott
1770 S. Amphlett Blvd
San Mateo, CA 94402
Ph: 650.653.6034. |
| Q: |
Does Nektar have a direct stock purchase plan? |
|
A: |
No, we do not have a direct stock purchase plan. |
| Q: |
Do you have a dividend reinvestment program (DRIP)? |
|
A: |
No, we do not have a dividend reinvestment program. |
| Q: |
How do I change my address on my stock certificate? Or change title of stock? What do I do if I lose my stock certificates? Who do I contact if I did not receive my annual proxy? |
|
A: |
Contact our transfer agent at the following address:
Mellon Investor Services LLC
ATTN: Sharon Magidson
235 Montgomery Street, 23rd floor
San Francisco, CA 94104-2902
415.743.1428 |
| Q: |
What is a transfer agent? |
|
A: |
Transfer agents maintain stock registries for their client companies, such as Nektar. They issue and cancel stock certificates, resolve issues around lost or stolen certificates, and answer questions from stockholders about their accounts |
| Q: |
When was Nektar founded? |
|
A: |
Nektar (formerly Inhale Therapeutic Systems, Inc.) was founded in 1990; our IPO occurred in May 1994. The company changed its name to Nektar on January 15, 2003, following the acquisition of Bradford Particle Design plc (January 2001) and Shearwater Corporation (June 2001). |
| Q: |
Who is your auditor? |
|
A: |
Ernst & Young LLP, Palo Alto, CA. |
| Q: |
Does Nektar issue dividends? |
|
A: |
Not at this time. |
| Q: |
How many shares of common stock are outstanding? |
|
A: |
Approximately 89.1 million shares of common stock are outstanding. |
| Q: |
What do I need to do to exchange my stock from Inhale to Nektar? |
|
A: |
Nothing at all. Your stock certificates will remain valid in the name of Inhale. |
| Q: |
What is the difference between a registered stockholder and a street-name stockholder? |
|
A: |
You are a registered holder if you are in possession of a stock certificate. You are a street-name holder if your broker holds your shares in an account for you. |
| Q: |
What is Nektar's disclosure policy? |
|
A: |
Nektar Therapeutics has programs and policies in place to comply with Regulation Fair Disclosure. Nektar discloses material information in its SEC filings, press releases, open conference calls, and webcasts conference calls at analyst and industry meetings.
Financial Results Announcements
In connection with announcing the company's quarterly financial results, Nektar will provide a press release with results attached and will post this press release and results on its company website. The company also will conduct a webcast conference call.
Guidance
From time to time, Nektar will provide guidance to analysts and investors in a public forum open to all as part of a webcast conference call or presentation. Nektar disclaims any duty to update financial guidance.
|
Home 
FAQ 